browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
aff38dd0-d36b-4325-86e8-273f3432cb16
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 18:27:05
Income (reported)
$15,000
Expenses (reported)
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

EMERGENT STRATEGIES

government affairs consulting firm

Contact
SCOTT ECKART
Phone
+1 202-907-5767
Address
zip:20002, city:WASHINGTON, state:DC, street:320 MASSACHUSETTS AVE NE

Client

ADVAMED:ADVANCED MEDICAL TECHNOLOGY ASSOCIATION

trade association representing the advanced medical technology industry

State
DC
Country
US
Government-entity client
false
Effective date
2021-09-01

Issues lobbied + lobbyists

MED — Medical/Disease Research/Clinical Labs

Health tax issues and trade Issues related to Small Business Innovation Research Program PAHPA Reauthorization

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TAX — Taxation/Internal Revenue Code

Issues relating to health tax issues and trade

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

CPI — Computer Industry

Issues related to health data privacy

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TRD — Trade (domestic/foreign)

Issues related to CHIPS implementation and medical supply chains Issues related to National Defense Authorization Act

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MMM — Medicare/Medicaid

Issues on legislation pertaining to S.1717 Ensuring Patient Access to Critical Breakthrough Products Act of 2025 Issues related to transitional coverage of emerging technologies

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.